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1. Introduction
Most popular formulation dispersing a hydrophilic compound into oil phase such as soybean
oil is emulsions. An emulsion is a dispersed system that consists of water, oil, and surfactant. In
general, apparatuses of an emulsifier, a homogenizer, etc. are used for the preparation. As the
pharmaceutical trial to disperse water-soluble compounds in an oil phase, the form of the
emulsion is very important. Namely, for pharmaceutical preparations containing a hydrophil‐
ic drug dispersed uniformly into the oil phase, water-in-oil (w/o) and water-in-oil-in-water
(w/o/w) emulsions are preferred. In these cases, hydrophilic drug molecules must retain a
high-density in the dispersed water phase of the emulsion; doing so depends on the oil-to-wa‐
ter partition coefficient of the drug. Furthermore, decreasing the particle size in the dispersed
water phase is necessary. Much pharmaceutical technical information about adjusting the size
of particles is now available: for example, rotating membrane emulsification [1, 2], shirasu po‐
rous glass membrane emulsification [3, 4], electrocapillary emulsification [5, 6]. These meth‐
ods adjust particle size on the basis of membrane pore size and shearing force, which depends
on the flow of dispersion medium or on contact-surface dielectric constant differences be‐
tween the dispersion medium and the dispersion phase. Therefore, these technologies are ad‐
vantageous in that they can produce uniform particle sizes. In this chapter, a simple method of
preparing w/o emulsions with a narrow range of polydispersity is described. In this method, a
Polytron homogenizer and an evaporator are used as apparatuses. Namely, specific and ex‐
pensive apparatuses were not used. Glycyrrhizin monoammonium (GZ) and indocyanine
green (ICG) were used as a hydrophilic compound. Here, the phase behavior, stability in terms
of particle size of w/o emulsions prepared using the novel method and the sustained release
characteristics drug from nano-sized w/o emulsions were investigated [7, 8].
© 2013 Koga; licensee InTech. This is an open access article distributed under the terms of the Creative
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2. Selection of emulsifier for the preparation of stable w/o emulsion
The choice of ideal emulsifier is an important to prepare physicochemically stable w/o emul‐
sion. Furthermore, the emulsifier must be safe in human. Therefore, mainly non-ionic sur‐
factants added in foods or medicines were chosen. The list used in this experiment was
shown in Table 1.
No. Surfactants Product name HLB
1                  condensed ricinoleic acid tetraglycerin ester CR-3101) 2.5
2                  polyethyleneglycol distearate ester CDS-4002) 8.5
3                  hexaglycerin sesquistearate ester SS-5001) 10.1
4                  tetraglycerin monostearate ester MS-3101) 10.2
5                  tetraglycerin monooleate ester MO-3101) 10.2
6                  tetraglycerin monolaurate ester ML-3101) 10.3
7                  polyethyleneglycol(10EO) monostearate ester MYS-102) 11
8                  hexaglycerin monostearate ester MS-5001) 12.2
9                  hexaglycerin monooleate ester MO-5001) 12.2
10                  polyethyleneglycol(10EO) monolaurate ester MYL-102) 12.5
11                  stearyl macrogol glycerides GELUCIRE 50/133) 13
12                  hexaglycerin monolaurate ester ML-5001) 13.5
13                  lauroyl macrogol-32 glycerides GELUCIRE 44/143) 14
14                  decaglycerin monooleate ester MO-7501) 14.5
15                  Polyethyleneglycol (25EO) monostearate ester MYS-252) 15
16                  decaglycerin monolaurate ester DECAGLYN 1-L2) 15.5
17                  decaglycerin monolaurate ester ML-7501) 15.7
18                  polyoxyethylene(20EO) oleylether BO-202) 17
19                  polyethyleneglycol(40EO) monostearate ester MYS-402) 17.5
20                  polyoxyethylene(30EO) phytosterol BPS-302) 18
21                  polyoxyethylene(21EO) laurylether BL-212) 19
22                  polyoxyethylene(18EO)nonylphenylether NP-18TX2) 19
23                  polyoxyethylene(25EO)laurylether BL-252) 19.5
24                  polyoxyethylene(30EO)octylphenylether OP-302) 20
25                  polyoxyethylene(20EO)nonylphenylether NP-202) 20
Number 1), 2), and 3) indicated in product name were gifts from Sakamoto Yakuhin Kogyo Co.Ltd., Nikko Chemicals
Co. Ltd., and Gattefossé, respectively.
Table 1. Surfactants used for the preparation of w/o emulsions.
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The following examination was carried out in order to estimate the stability of w/o emul‐
sion. Each surfactant (0.75 g) and soybean oil (6.75 g) were put in a glass tube. The mixture
was dissolved or dispersed uniformly at 60°C for 15 min. GZ solution (2.25 mL of 40 mg/mL
in dissolved with 100 mM phosphate buffered solution, pH7.4) was added into the glass
tube, then immediately, the solution with oil, water phase, and surfactant was emulsified
using a Polytron homogenizer (PT-MR 3100, Kinematica AG, Littau/Luzern, Switzerland) at
20,000 rpm for 3 min. The state of the w/o emulsions was observed at 24 h after the prepara‐
tion. The stability of the w/o emulsions was estimated by objective evaluation scale (OES; 0,
1, 2, 3, 4, and 5). Namely, OES 0 is a completely discrete state without emulsifying. OES 1 is
a biphasic separate state with wispy cloud in bottom phase, OES 2 is a biphasic separate
state with weakly white turbidity in bottom phase, OES 3 is a biphasic separate state with
moderately white turbidity in bottom phase, OES 4 is a biphasic separate state with strongly
white turbidity in bottom phase, and OES 5 is a stable state without phase separation.
Figure 1. Observed properties of emulsions with 24 kinds of emulsifiers at 24 h after the preparation using a Polytron
homogenizer. The photo of emulsion with CR-310 was referred in Figure 3A. The number under each photo is a prod‐
uct number shown in Table 1.
The results in the observed state after preparation of w/o emulsions are shown in Figure 1.
Moreover, Figure 2 shows the relationship between HLB number of emulsifiers and OES.
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CR-310 and CDS-400 among 25 kinds of surfactants were convenient for the preparation of
stable w/o emulsion. The results were identified with the theory that surfactant with low
HLB is suitable for the preparation of w/o emulsions. A difference of viscosity as physico‐
chemical properties was observed between CR-310 and CDS-400. Namely, the viscosity of
the w/o emulsion with CDS-400 was high like cream, that of the emulsion with CR-310 was
the same as the viscosity of soybean oil. Therefore, it was clear that CR-310 among used sur‐
factants was most convenient emulsifier for the preparation of w/o emulsions when soybean
oil was used as an oil phase.
Figure 2. The relationship between HLB number of surfactants and objective evaluation scale. The number of each
symbol is a product number shown in Table 1.
3. Preparation of nano-sized w/o emulsions
GZ solution (400 mg/mL) was prepared by dissolving GZ powder at 60°C in 100 mM phos‐
phate-buffered solution (pH7.4) containing 8.0% (w/v) L-arginine. L-arginine was used to in‐
hibit the gelation of GZ [9]. Soybean oil (4.50 g) and CR-310 (0.50 g) were mixed in a glass
tube, and then the mixture was heated for 15 min at 60°C in order to blend uniformly. The
GZ solution and the mixture of oil and emulsifier were cooled down at room temperature,
and 400 mg/mL GZ solution (2.2, 3.3, or 4.4 g) was added to glass tubes containing the mix‐
ture. First, the w/o emulsions were prepared by agitating the mixture with a Polytron ho‐
mogenizer (PT-MR 3100, Kinematica AG) at 20,000 rpm for 3 min. Second, the w/o
emulsions were placed into a 50-mL round-bottom flask, which was then placed into a rota‐
ry evaporator (R-210, Buchi Labortechnik AG, Flawil, Switzerland) equipped with a vacuum
controller (V-850) and a vacuum pump (V-700). The vacuum was initially set to 120 hPa, and
then decreased at a rate of 10 hPa per minute until 20 hPa was reached. The mixture was
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then subjected to these vacuum conditions at 40°C for 90 min. The prepared emulsions were
separated into either glass vials or 10-mL centrifuge tubes, depending on the analyses to be
done. For phase behavior comparisons, w/o emulsions without GZ was also prepared using
distilled water (3.3 g) instead of GZ solution [7].
4. Phase behavior during the preparation of w/o emulsions
The w/o emulsions prepared by adding GZ solution slowly changed in turbidity to pale
white, and after 23-24, 26-27, and 31-32 min for GZ solutions of 2.2, 3.3, and 4.4 g, respective‐
ly, to clear or slightly turbidity. The samples remained clear only for approximately 2 min.
When subjected to prolonged evaporation, the emulsions rapidly changed in turbidity to
white as solid dispersion. Figure 3A shows photographs of the emulsions prepared with GZ
before evaporation (0 min) and 10, 15, 26, and 90 min after evaporation. To confirm the rela‐
tionship between evaporation time and phase behavior in w/o emulsions with or without
GZ, similar experiments on w/o emulsions lacking GZ were carried out (Figure 3B). The tur‐
bidity of w/o emulsions without GZ remained white up to 15 min after evaporation, before
gradually changing to pale white. The w/o emulsions finally became transparent 90 min af‐
ter evaporation. These results suggest that the phase behavior may depend on the water
content of the w/o emulsions.
Figure 3. Photographs of w/o emulsions at the indicated times after evaporation. (A) Emulsion prepared with a GZ
solution containing 3.3 g GZ. (B) Emulsion prepared without GZ (water phase is distilled water). The times shown be‐
low each vial represent the length of time samples underwent evaporation.
5. Particle size of water phase in w/o emulsions
GZ solution (400 mg/mL) was prepared by dissolving GZ powder at 60°C in 100 mM phos‐
phate-buffered solution (pH 7.4) containing 8.0% (w/v) L-arginine and 10 µg/mL fluorescein
sodium. Fluorescein sodium was used as a marker for the fluorescent observation of the dis‐
persion state of water phase in the emulsions. After the GZ solution (3.3 g), soybean oil (4.50
g), and CR-310 (0.50 g) were mixed, w/o emulsions were prepared according to the method
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described above. The w/o emulsion before dehydration was analyzed with a confocal laser
scanning microscope LSM510 (Carl Zeiss GmbH, Jena, Germany) and LMS Image Browser
Software (Carl Zeiss GmbH). The excitation and fluorescein wavelengths were set to 405
and 488 nm, respectively.
Figure 4. Fluorescence photomicrograph of a w/o emulsion following the addition of fluorescein sodium to the water
phase. The dark gray areas represent the aqueous phase. The position of water phase containing GZ is indicated as
green fluorescent particles.
Figure 4 shows the photo by a confocal laser scanning microscope. The water phase was uni‐
formly distributed as small droplets (< 5 µm), indicating that before evaporation the particle
size distribution in the water phase of GZ sample distributed widely after dispersal with a
Polytron homogenizer.
Emulsions Particle size in relative frequency (nm)
10% 25% 50% 75% 90%
2.2 g GZ sample 135 170 225 287 341
3.3 g GZ sample 219 253 299 349 394
4.4 g GZ sample 310 504 1105 1381 1610
Table 2. Particle size and size distribution of clear or slightly turbid w/o emulsions.
The particle sizes of w/o emulsions at 23, 26, and 31 min for GZ solutions of 2.2, 3.3, and 4.4
g after evaporation were analyzed using a Particle Size Analyzer (LS 13 320; Beckman Coult‐
er, Inc., Fullerton, CA, United States). Table 2 presents the average particle sizes and size
distributions of the clear or slightly turbid w/o emulsions after evaporation. The size distri‐
bution of the three kinds of emulsions was narrow, with relative frequency values of 10, 25,
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75, and 90%. These results suggest that dehydration proceeded in a way that caused the dis‐
persed phase to approach the narrow distribution. In particular, the particle size distribution
of the 2.2 and 3.3 g GZ samples converged toward the nano-size range. This was consistent
with our prediction that large water droplets would efficiently evaporate from the surface of
the w/o emulsions as their round bottom flasks were rotated and that particle size distribu‐
tion would narrow as a function of evaporation time.
During the preparation of transparent w/o emulsions containing GZ, the only component
removed by evaporation was water. Thus, the components dissolved in the water phase
(GZ, L-arginine, and phosphate salts) were gradually concentrated as the water content de‐
creased. The observation that a simple evaporation process changed the turbidity of the w/o
emulsions from white to clear within a short time suggests that the particles comprising the
dispersed phase became extremely small in size. In fact, the particle size range of sample
which prepared with 3.3 g GZ solution was 219-394 nm by dynamic light scattering assay
(LS 13 320; Beckman Coulter, Inc.). The state of the nano-sized droplets was observed in
transmission electron microscopy (TEM). Namely, a clear w/o emulsion was prepared by
adding GZ solution (3.3 g) to the mixture of soybean oil (4.50 g) and CR-310 (0.50 g), and the
resulting clear w/o emulsion was passed through a quantitative filter (No. 5B, Advantec;
Toyo Roshi Kaisha, Ltd., Tokyo, Japan). The filter was then hardened with cured acryl resin.
After embedding the filter, ultrathin sections were obtained by cutting the surface of the
block containing the filter on an ultramicrotome equipped with a diamond knife (EM-Ultra‐
cut-s; Leica Microsystems Vertrieb GmbH, Wetzlar, Germany). The ultrathin sections were
mounted onto freezing support grids and then stained with ruthenium tetrachloride. Next,
the emulsified particles were observed with a transmission electron microscope (TEM;
JEM-2100; Jeol Ltd., Tokyo, Japan).
Figure 5. A) TEM photograph of dispersed particles in a clear w/o emulsion prepared by adding GZ solution. (B) Solid
GZ particles after 90 min evaporation.
To determine whether the nano-sized droplets exist as a liquid state in the water phase, the
shape of particles in the clear w/o emulsion (3.3 g GZ sample) was observed with TEM. As the
water content of the emulsion decreases with evaporation, part of the dissolved GZ may pre‐
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cipitate as a solid state from the dispersed phase. If this hypothesis is accurate, then the parti‐
cles may be not spherical. However, TEM analysis revealed that the particles were spheres of
approximately 200 nm in diameter and were maintained a uniform globe (Figure 5A), strongly
suggesting that the nanoparticles in the clear w/o emulsions existed as a liquid phase.
Following additional evaporation, the turbidity of the w/o emulsions again changed to
white, indicating a change in phase behavior. This suggests that the hydrophilic components
dissolved in the water phase separated as solid states. In fact, microscopic analysis demon‐
strated that the w/o emulsions containing GZ contained 1-10 µm-diameter solid particles
>90 min after evaporation (Figure. 5B) [8].
6. Water contents in w/o emulsions
The water content (%, w/w) of the w/o emulsions was analyzed using a Karl Fischer titration
apparatus (870, KF Titrino Plus; Metrohm Shibata Co., Ltd., Tokyo, Japan). The water content
(%, w/w) of the 2.2, 3.3, and 4.4 g GZ samples before evaporation was 16.8, 21.9, and 25.4%
(w/w), respectively. On the other hand, the water content of the clear or slightly turbid 2.2, 3.3,
and 4.4 g GZ samples was 7.8 ± 0.1, 9.4 ± 0.3, and 11.9 ± 0.3% (w/w), respectively. Furthermore
after 90 min of evaporation, the water content of the 2.2, 3.3, and 4.4 g GZ samples was all in the
range of 1.3-1.8% (w/w). The water content of w/o emulsion lacking GZ was 9.3 ± 0.2 and 0.18 ±
0.02% (w/w), respectively, at 26 and 90 min after evaporation. These results indicate that the
phase behavior of the w/o emulsions changed from white turbid to translucent or transparent
when the water content reached approximately 8-12% (w/w). Since the water content of the
clear or slightly turbid w/o emulsions correlated well with GZ content (0.8, 1.2, and 1.6 g for 2.2,
3.3, and 4.4 g GZ samples; correlation coefficient was 0.992), it is plausible that the precipita‐
tion of hydrophilic components, such as GZ, L-arginine and phosphate salts, was responsible
for the increased turbidity resulting after prolonged evaporation.
From these results, it is concluded that the water contents of w/o emulsions changed the
phase behavior in the emulsions, that is, from white turbid phase to clear phase when the
water content reached to be approximately 9%, and then from clear phase to white turbid
phase. The decreasing rate of the water content is affected by the setting of a vacuum con‐
troller. In the experiments, although the relationship between the decreasing rate of the wa‐
ter content and maintained interval with clear phase in the w/o emulsions was not
investigated, the pressure condition in the evaporation process will be a major problem for
the simple preparation of clear w/o emulsions.
7. Stability of w/o emulsions
The stability of the w/o emulsions were evaluated according to two criteria: i) the uniform
dispersal of the water phase containing GZ in the emulsion; and ii) the size distribution at
steady-state conditions. Clear or slightly turbid w/o emulsions (2.2, 3.3, and 4.4 g GZ solu‐
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tions) were transferred to 10-mL centrifuge tubes (Figure 6), which remained undisturbed at
20 ± 2°C for 10 days. The w/o emulsion prepared with 3.3 g GZ solution remained under
undisturbed conditions continuously for 65 days. Next, a pipette was inserted 1 cm from the
top or bottom of each centrifuge tube and a small amount (50 mg) of emulsion was removed
and transferred into two screw vials (one vial for the “top” sample, the other vial for the
“bottom” sample). Methanol (30 mL) was added to each vial, and the vials were shaken for
15 min on a vortex mixer. The methanol-containing GZ samples were adequately diluted
with 100 mM phosphate-buffered solution (pH 7.4) and were injected into an HPLC system
in order to determine the GZ concentration in the samples [10]. The water content (%, w/w)
in the w/o emulsions obtained from both samples was analyzed by Karl Fischer titration.
Figure 6.  Photograph of  clear  and slightly  turbid  w/o emulsions.  (A)  2.2  g  GZ sample.  (B)  3.3  g  GZ sample.  (C)
4.4 g GZ sample.
7.1. Uniformity of GZ concentration and water content in w/o emulsions
The GZ concentrations of 2.2, 3.3, and 4.4 g GZ samples that were clear or slightly turbid
were 11.1, 14.5, and 17.0% (w/w), respectively. The GZ concentrations and water content
of clear or slightly turbid w/o emulsions 10 days and 65 days after preparation are shown
in Table 3.  As the phase behavior changes with time,  the aggregation or  coalescence of
the dispersed phase occurs more frequently after emulsification is achieved, because the
emulsion is thermodynamically unstable. If the dispersed stability is not maintained, then
the  GZ concentration  and water  content  in  the  emulsion  will  differ  in  the  parts  of  the
emulsion near the top and bottom of the sample. This is because the dispersed phase con‐
taining GZ moves toward the bottom due to specific  gravity differences.  GZ concentra‐
tion in the samples were analyzed in the present study, however, the GZ concentrations
in the top and bottom parts of the emulsions were identical in the 2.2 and 3.3 g GZ sam‐
ples  but  not  in the 4.4  g  GZ sample.  Furthermore,  similar  results  were obtained in our
comparative analysis of water content. These results suggest that the dispersed stability of
the 2.2 and 3.3 g GZ w/o emulsions was extremely high. On the other hand, the differ‐
ence in phase behavior in the top and bottom layers of the 4.4 g GZ sample suggests dis‐
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persed  instability.  Specifically,  after  10  days  the  turbidity  of  the  bottom  layer  became
clearer than that of the top layer, indicating that the dispersed phase containing 4.4 g GZ
gradually moved toward the bottom of the 10-mL centrifuge tube. The specific gravity of
the dispersed phase in the w/o emulsions increased with increasing GZ concentration.
w/o emulsions GZ concentration (%, w/w) Water content (%, w/w)
upper position bottom position upper position bottom position
2.2 g GZ sample 11.5 ± 0.7 11.2 ± 0.4 8.2 ± 0.2 8.4 ± 0.2
3.3 g GZ sample 14.9 ± 0.5 14.7 ± 0.5 10.1 ± 0.2 10.2 ± 0.3
3.3 g GZ sample** 15.0 ± 0.4 14.8 ± 0.4 9.8 ± 0.3 9.6 ± 0.2
4.4 g GZ sample 10.2 ± 0.8 17.4 ± 0.7 7.4 ± 0.1 12.0 ± 0.3
GZ concentration and water content were determined after the sample was stored undisturbed for 10 days at 20 ±
2°C. *Samples were obtained 1 cm from the top and bottom of the emulsions contained within a 10-mL centrifuge
tube. **The sample was stored undisturbed for 65 days at 20 ± 2°C.
Table 3. GZ concentration and water content in different parts of the w/o emulsions*.
7.2. Uniformity of particle size of dispersed phase in w/o emulsions
The particle size distribution of the GZ sample containing 3.3 g GZ solution at 65 days after
preparation was 226-421 nm. This range was similar to that measured during immediate in‐
tervals after preparation. In general, refinement of emulsion particle size lowers thermody‐
namic stability, because the phase behavior of an emulsion-which is a very complicated
system of oil, water, and surfactant-is affected by decreases in particle size [11]. Nano-sized
emulsions, in particular, are not as stable as micron-sized emulsions. Therefore, nano-sized
emulsions must be stabilized with polymers and excessive amounts of surfactants [12]. In
GZ sample, the concentration of surfactant in the oil phase was 10% (w/w); the emulsions
did not contain other stabilizers. However, the GZ sample (nano-sized emulsions) was sta‐
ble at least for 2 months. Moreover, although the particle sizes of the top and bottom layers
in the 4.4 g GZ sample were not determined, the aggregation of dispersed particles suggests
that the size distribution in this w/o emulsion tended to be on the large side. Taken together,
these observations suggest that dispersed stability decreases with increasing GZ content.
8. Sustained release effect by nano-sized w/o emulsions
From the viewpoint of medical treatment, drug release from w/o emulsions is important for
the efficiency of controlled release. The pharmacokinetics of GZ by nano-size w/o emulsion,
aqueous formulation, o/w emulsion, and w/o emulsion with solid GZ was investigated in
order to clarify the degree of the controlled release. Furthermore, the release characteristics
of a hydrophilic compound, indocyanine green (ICG), from administered subcutaneous site
in rats was observed using a near-infrared fluorescent camera (Photo Dynamic Eye, PDE).
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8.1. In vivo experiments in GZ pharmacokinetics
Pharmacokinetic studies of GZ were investigated in detail in human [13, 14], in rat [15, 16],
and other species. The elimination half-life of GZ in rats after the intravenous administration
(20-50 mg/kg) is approximately 2-4 h in plasma [17, 18]. GZ is rapidly excreted into bile via
multidrug resistance-associated protein 2 (MRP2) ATP-binding cassette transporter C2
(ABCC2) transporter [19]. Therefore, the release of GZ from w/o emulsions was estimated as
GZ elimination into bile.
The protocol of this study was approved by the Committee of Animal Use of Hokuriku Uni‐
versity. All animal experiments were conducted in accordance with the Institutional Guide‐
lines of Care and Use of Laboratory Animals. Male Sprague-Dawley rats (180-200 g) were
housed for at least 10 days in a clean room. The rats were given free access to commercial
chow and water and were maintained according to the Hokuriku University Animal Guide‐
lines. For in vivo experiments in GZ formulations, the rats (250-280 g) were randomly divid‐
ed into four treatment groups as four rats per group.
A GZ stock solution (400 mg/mL) was prepared at 60°C in 100 mM phosphate-buffered solu‐
tion, pH7.4, containing 8.0% (w/v) L-arginine. The GZ stock solution was stored in a refrig‐
erator. An aqueous formulation of GZ (150 mg/mL; Rp-II) was prepared by adding 100 mM
phosphate-buffered solution (pH7.4) to the GZ stock solution. Preparation of an oil-in-water
(o/w) emulsion of GZ was as follows: soybean oil (1.00 g), HCO-60 (0.12 g), and egg yolk
lecithin (0.12 g) were blended uniformly by heating at 90°C for 15 min on a block heater. The
mixture was then cooled at room temperature. The o/w emulsion of GZ (150 mg/mL; Rp-III)
was prepared by combining the soybean oil mixture (1.0 mL), GZ stock solution (1.16 mL),
and 100 mM phosphate-buffered solution, pH7.4 (0.84 mL) and by using a Polytron homog‐
enizer (PT-MR 3100) at 20000 rpm for 3 min for emulsification.
Preparation of an w/o emulsion of GZ was described above. The GZ stock solution (3.3 g)
was then added to the lukewarm mixture, which was emulsified using a Polytron homoge‐
nizer (PT-MR 3100) at 20000 rpm for 3 min. The w/o emulsion was placed into a 50-mL
round-bottom flask, which was then set in a rotary evaporator (R-210, Buchi Labortechnik
AG) equipped with a vacuum controller (V-850). The vacuum was initially set to 120 hPa at
40°C; thereafter, the pressure was decreased at a rate of 10 hPa per min until 20 hPa was
reached. To prepare Rp-I and Rp-IV, the dehydration was continued for 27 min and 120
min, respectively, and then adjusted the GZ concentration to 150 mg/mL by adding the soy‐
bean oil/CR-310 (9 : 1, w/w) mixture. Adminidtration method of four kind formulations and
sampling of bile in rats were described in detail in reference [8].
As the characteristics of used formulations, the average particle sizes in the Rp-I and Rp-III
formulations were 299 nm and 376 nm, respectively. The 10-90% ranges of size distribution
in Rp-I and Rp-III were 208-402 nm and 255-512 nm, respectively. Two peaks in size distri‐
bution were observed in the Rp-IV formulation: 312 nm and 5000 nm. Microscopic observa‐
tions revealed that large-size GZ particles were solid GZ, because they were not spherical.
The water content in Rp-IV (1.5%, w/w) was very low compared with that in Rp-I (9.4%,
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w/w). Moreover, the small- and large-size particles were not observed after evaporation for
120 min in a w/o emulsion lacking GZ.
Almost all GZ transported to hepatocytes via the blood is eliminated into bile as unchanged
GZ (i.e., not metabolized) [20, 21]. Therefore, the elimination rate of GZ in bile reflects the
bioavailability of GZ in hepatocytes. Figure 7 shows the cumulative elimination (%) of GZ
over time after subcutaneous administration of Rp-I, Rp-II, Rp-III, and Rp-IV in rats. After
the administration of Rp-I, cumulative elimination at 8 h, 24 h, and 72 h as a function of ad‐
ministered GZ dose (50 mg/kg) in bile was 11%, 20%, and 47%, respectively. These results
indicate that the Rp-I formulation resulted in a sustained release of apparent zero-order ki‐
netics. The average elimination rate of GZ up to 72 h was 84.2 ± 14.2 µg/h.
Figure 7. Cumulative elimination of GZ in bile after subcutaneous administration of GZ formulations in rats. (A) Nano-
sized w/o emulsion encapsulating GZ, (B) aqueous solution of GZ, (C) o/w emulsion containing GZ, and (D) w/o emul‐
sion with solid GZ. GZ concentrations were all adjusted to 150 mg/mL. The GZ dose administered to all rats was all 50
mg/kg. Data represent means ± S.D. of four experiments.
With the Rp-II formulation, the cumulative elimination at 4 h and 8 h as a function of ad‐
ministered GZ dose was 75% and 97%, respectively. In intravenous and subcutaneous ad‐
ministration models, no difference in the elimination rate of GZ has been observed after
intravenous administration of GZ [10]. These results suggest that GZ dissolved in phosphate
buffered solution rapidly diffused in the hyperdermis, before being transferred into the gen‐
eral circulation. With the Rp-III formulation, the cumulative elimination of GZ at 8 h and 30
h was 81% and 96%, respectively. The elimination rate of GZ in Rp-III was faster than that in
Rp-I but slower than that in Rp-II, suggesting that the oil phase of the o/w emulsion inhibit‐
Soybean - Bio-Active Compounds422
ed the diffusion of the water phase containing GZ in subcutaneous regions, even though GZ
was dissolved in the outer water phase of o/w emulsion. On the other hand, the cumulative
elimination of GZ in Rp-IV was the lowest among the four formulations: The GZ elimination
in bile at 8 h, 24 h, and 72 h was 7.1%, 14%, and 31%, respectively. As with the elimination
kinetics of the Rp-I formulation, the elimination kinetics of GZ in Rp-IV showed that GZ
was released in a sustained fashion for up to 72 h. Since Rp-IV contained solid GZ in w/o
emulsions, it was speculated that the elimination rate of GZ in bile after the administration
of Rp-IV would be slower than that of GZ in Rp-I. In fact, the eliminated amount of GZ in
bile after the administration of Rp-IV was 0.64-fold compared to that of Rp-I. These results
suggest that reduced water content in w/o emulsions delays hydration in the subcutaneous
region and that much time is required to dissolve the dispersed solid GZ in Rp-IV.
To determine more precisely the characteristics of sustained GZ release from w/o emulsions,
the rates of GZ elimination in bile were recalculated every 24 h after the administration of
Rp-I and Rp-IV (Figure 8).
Figure 8. Elimination rate per 24 h of GZ in bile after subcutaneous administration of Rp-I and Rp-IV in Rats. Adminis‐
tration dose of GZ was 50 mg/kg in both formulations. Data represent means ± S.D. of four experiments.
The elimination of GZ in Rp-I occurred at a constant rate for 72 h, i.e., the rate ranged from 1.80
to 2.12 mg/day. On the other hand, elimination of GZ in Rp-IV decreased from 1.40-1.41
mg/day at 48 h to 0.60 mg/day at 48-72 h. As the reason for the decrease in GZ elimination rate
at 48-72 h in Rp-IV, it was predicted that the presence of solid dispersed GZ may be involved
deeply the transfer rate of GZ from subcutaneous site to liver. Actually, dissolved-state GZ and
solid-state GZ exist in Rp-IV. Although it was considered that the dissolved GZ in Rp-IV was
transferred to liver as similar to GZ in Rp-I, solid GZ particles must be dissolved to some extent
which can be passed vascular system such as vein and lymph capillary in order to transfer GZ
from subcutaneous site to liver. Therefore, after 48 h, the proportion of solid GZ for residual
GZ in the subcutaneous site will increase certainly. As a result, it was guessed that GZ elimina‐
tion into bile decreased based on the decrease of transfer rate from subcutaneous site to liver.
These results indicate that Rp-I was a substantially superior formulation compared to Rp-IV in
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terms of sustained release in bile. It was hypothesized that the small and narrowrange polydis‐
persity (208-402 nm in Rp-I) of the dispersed phase in w/o emulsions may be important for sta‐
bilizing the release rate of GZ from these emulsions.
8.2. Tissue distribution of ICG from subcutaneous site in rats
For the experiments of ICG administration, two male Sprague-Dawley rats (250, 255 g) were
used. A w/o emulsion encapsulating ICG was prepared as follows: 5 mg/mL ICG solution (3.3
g) was added to the mixture of soybean oil (4.50 g) and CR-310 (0.50 g) heated at 60°C. Next
procedure was the same with the preparation step of Rp-I described above. This ICG solution
and w/o emulsion encapsulating ICG were used to observe the tissue distribution of drugs
from the subdermal injection site. To monitor over time the delayed drug distribution and the
diffusion of hydrophobic formulation in the subdermal site, a w/o emulsion encapsulating
ICG instead of GZ was prepared. ICG is a hydrophilic fluorescent dye and biocompatibility
marker with excitation and emission spectra in the near-infrared wavelength range of 600 to
900 nm, and the maximum emission wavelength of ICG in vivo is 845 nm [22, 23]. The kinetics
of ICG in vivo was observed using a non-invasive, near-infrared fluorescent camera (Photo
Dynamic Eye; PDE), because the near-infrared-wavelength monitoring barely affects biologi‐
cal molecules such as water and hemoglobin. For the experiments of the microscopic image us‐
ing a fluorescent probe, ICG, rats were anesthetized with an intraperitoneal administration of
sodium pentobarbital (50 mg/kg), and then were kept in a supine position on an operation
plate. A PDE was set on the upper position of 20 cm from the rat and the photo image was
monitored using a personal computer. Two samples, 5 mg/mL ICG solution (0.05 mL) and w/o
emulsion encapsulating ICG (0.05 mL) were administered to right and left hind legs of rat, re‐
spectively. The diffusion of ICG was observed for 60 min.
Figure 9. Photographs taken at (A) 15 min and (B) 60 min after the subcutaneous injection of ICG solution into the right
leg and w/o emulsion encapsulating ICG into the left leg injection volume of ICG was 50 mL in both formulations.
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The purpose of the PDE experiments was to determine whether the diffusion rate of w/o
emulsions at the subdermal site is remarkably slower than that of solutions like Rp-II of GZ
formulation. Figure 9 shows photographs of rats’ hind legs 15 min and 60 min after injecting
ICG (right leg) and after injecting w/o emulsion encapsulating ICG (left leg). The ICG solu‐
tion was rapidly absorbed into capillary blood vessels within 15 min. Furthermore, ICG also
reached peripheral lymphatics. On the other hand, ICG in w/o emulsions remained in the
vicinity of the administration site for 60 min. These results suggested that the outer oil phase
inhibited the diffusion of w/o emulsion encapsulating ICG and/or the release of ICG from
the w/o emulsion. The viscosity of lipophilic formulations is generally high. Therefore, one
would expect the release of ICG from a w/o emulsion to be delayed compared to that from
aqueous formulations of ICG. The expectation will be correspondent with the decrease of
diffusion and/or release of GZ from Rp-I of GZ formulation.
9. Conclusion
It was clarified that GZ, a hydrophilic compound, was dispersed as nanoparticles into soy‐
bean oil by using the evaporation technique. The prepared oil phase containing GZ was
nano-emulsions with low polydispersity, and was stable at least 2 months. This ideal disper‐
sion method had to make water content approximately 9%, and it was clear that the further
dehydration became solid dispersion. It is concluded that a hydrophilic compound can be
dispersed easily into an oil phase such as soybean oil by utilizing this method. Concretely,
the w/o emulsions containing GZ (2.2 g of GZ [11.1%, w/w] and 3.3 g of GZ [14.5%, w/w])
with narrow-ranged polydispersity and high-dispersed stability were easily prepared by the
measurable removal of water using a Polytron homogenizer and a rotary evaporator. The
water content in 2.2 and 3.3 g GZ samples had to be 7.8 and 9.4% (w/w), respectively, be‐
cause decreasing the water content beyond these levels caused the phase behavior to change
(e.g., white turbid). The particle size distribution (relative frequency values ranging from 10
to 90%) of the clear w/o emulsions was in the range of 135 to 421 nm as the samples re‐
mained undisturbed for 65 days at 20 ± 2°C. The w/o emulsion preparation method descri‐
bed in the present study provides useful information on the lipophilic formulations of GZ.
A nano-sized w/o emulsion of GZ (Rp-I) showed sustained elimination of GZ in bile at a rel‐
atively constant rate for 72 h. The sustained GZ elimination in bile was strongly affected by
diffusion of the w/o emulsion and by the release of GZ from the emulsion to the perimeter
of the subdermal site, based on the PDE observations with ICG. Indeed, the average elimina‐
tion rate of GZ in bile was 0.084 mg/h over 72 h, when Rp-I (50 mg/kg as GZ) was adminis‐
tered subcutaneously. If GZ release from Rp-I will be maintained as zeroorder elimination
(0.084 mg/h), 6-7 day are needed until the GZ release finishes in the rats. Namely, GZ in Rp-I
will slowly transfer from subcutaneous tissue to liver 20-fold periods as compared with GZ
in Rp-II, the elimination of almost all GZ finished 8 h. These results indicate that the nano-
sized w/o emulsion encapsulating GZ, which can be subcutaneously administered, will be
useful as a new sustained-release formulation.
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